Shengda Biology: Shareholder Tian Tai Wanjian Investment plans to reduce its holding by no more than 3%.

SanDa Biotech announced that the shareholder Tian Tai Wan Jian Investment, holding 15.20% of the shares, plans to reduce its holdings through block trading by no more than 1.89 million shares and bulk trading by no more than 3.78 million shares from February 25, 2026 to May 24, 2026, totaling not more than 5.67 million shares, accounting for 3% of the company's total share capital. The maximum reduction limit for any consecutive 90 days is 1% and 2% respectively.